Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

Inherited retinal degenerations (IRDs) are a group of genetic disorders that lead to progressive vision loss as the ...

A density gradient of basement membrane laminins modulates retinal pigment epithelium contractility levels by differential ...

A collaborative team of researchers led by vision scientists from the School of Veterinary Medicine at the University of ...

National Institutes of Health (NIH) scientists have developed a new surgical technique for implanting multiple tissue grafts in the eye's retina.